Publication | Closed Access

A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia

Low DoseHematologyRetrospective AnalysisPathologyMedicineHereditary Haemorrhagic Telangiectasia